Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines

Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines Financial Times

Early report Major update Updated Mar 23, 2026, 4:33 PM UTC

Track this event Edit in app More event pages

What changed

FT: Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines.

First seen Mar 23, 2026, 4:33 PM UTC Latest source Mar 23, 2026, 4:33 PM UTC

Update 1 5h ago

FT •published Mar 23, 2026, 4:33 PM UTC •fetched Mar 23, 2026, 9:00 PM UTC